Research and Markets: Global Lung Cancer Vaccine Market & Pipeline Insight 2015

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/sl9wsf/global_lung) has announced the addition of the "Global Lung Cancer Vaccine Market & Pipeline Insight 2015" report to their offering.

Lung cancer incidences are rapidly increasing and various therapeutics have been introduced in global market to provide better care to patients. Surgery and radiation therapy are not preferred for lung cancer treatment due to which they have small global market size. Chemotherapeutics and targeted therapeutics for lung cancer treatment are major market contender in global market with wide acceptance levels among oncologists and patients. Chemotherapeutics have life threatening side effects while targeted therapeutics available in markets are quite effective therapeutics but they are unable to reduce the present lung cancer mortality rates. These drawbacks are not expected to be associated with lung cancer vaccines which will help in generating significant revenues and increased penetration across the globe.

Identification of novel targets for lung cancer vaccine development is underway by pharmaceutical companies to provide efficient medical care to patients. Many mechanisms and tumour antigen has been identified for the development of novel lung cancer vaccines. Different lung cancer vaccines will help the patients in deciding better therapeutic options and generate significant revenues for pharmaceutical companies. Pharmacological effects provided by these novel lung cancer vaccine is expected to help the lung cancer patients across the globe.

Global Lung Cancer Vaccine Market & Pipeline Insight 2015 Report Highlights:

- Introduction to Lung Cancer Vaccine

- Global Lung Cancer Vaccine Market Analysis

- Global Lung Cancer Vaccine Pipeline by Company & Phase

- Global Lung Cancer Vaccine Pipeline: 29 Vaccines

- Majority Lung Cancer Vaccines in Phase-II: 8 Vaccines

- Marketed Lung Cancer Vaccines: 3 ( BV NSCLC 001, Mycidac-C & Vaxira)

- Personalized Cancer Vaccines: Progress & Possibilities

- Lung Cancer Vaccine Mechanism

Key Topics Covered:

1. Introduction to Cancer Vaccines

2. Cancer Vaccines: Mechanism & Innovations

3. Introduction Global Lung Cancer Vaccine

4. Mechanism of Lung Cancer Vaccines

5. Global Lung Cancer Vaccine Market Outlook

6. Global Lung Cancer Market Dynamics

7. Global Lung Cancer Vaccine Market Future Prospects

8. Global Lung Cancer Vaccine Pipeline by Company & Phase

9. Marketed Lung Cancer Vaccine Clinical Insight

10. Suspended & Discontinued Lung Cancer Vaccines Pipeline by Company & Phase

11. Competitive Landscape

- Boehringer Ingelheim

- CureVac

- Eli Lily

- Galaxo

- ImClone Systems

- Merck

- Ono Pharmaceutical

- Oncothyreon Incorporation

For more information visit http://www.researchandmarkets.com/research/sl9wsf/global_lung

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices